HOME >> MEDICINE >> NEWS
American Academy of Neurology presents 56th Annual Meeting in San Francisco, April 24 - May 1, 2004

More than 10,000 are expected to attend the American Academy of Neurology 56th Annual Meeting in San Francisco, April 24 May 1, 2004.

Held in the Moscone Convention Center, the very latest research findings on dementia, Parkinson's disease, stroke, epilepsy, headache, multiple sclerosis and other neurological disorders will be included in more than 1,300 scientific studies presented as platform and poster sessions.

"The highly regarded science program at the Annual Meeting draws worldwide interest and provides neurologists access to cutting-edge research," said AAN president Sandra F. Olson, MD. "The 2004 scientific program covers the full spectrum of neurology, from prevention to diagnosis and treatment."

Key science presentations will be presented at four plenary sessions, starting with the Presidential Plenary Session on April 27 at 9:00 a.m. Eric R. Kandel, MD, of Columbia University, New York, N.Y., will give the Presidential Lecture on "Molecular Mechanisms for the Persistence of Memory Storage."

The Contemporary Clinical Issues and Case Studies Plenary Session will take place on April 28 at 9:00 a.m. A new addition to this session will be three case presentations focusing on multiple sclerosis, Parkinson's disease and the effect of estrogen in neurological disease.

On April 29 at 9:00 a.m., several physician-scientists will outline recent research findings, along with the clinical implications, during the Frontiers in Clinical Neurosciences Plenary Session: Beyond the Decade of the Brain. Among the presentations will be "Markers and Mediators of Neuronal Deficits in Dementia" by Lennart Mucke, MD, of the University of California, San Francisco.

The Scientific Program Highlights Plenary Session will conclude the plenary sessions on April 30 beginning at 5:15 p.m. after all educational programs have ended. As chair of the AAN Science Committee, John H. Noseworthy, MD, of the Mayo Clinic, Rochester, Minn., will mo
'"/>

Contact: Marilee Reu
mreu@aan.com
651-695-2789
American Academy of Neurology
1-Mar-2004


Page: 1 2

Related medicine news :

1. Consumers with disabilities empowered by American Disabilities Act
2. Definition of persistent vegetative state available from American Academy of Neurology
3. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
4. New colorectal cancer screening recommendations for African Americans
5. American Thoracic Society Journal news tips for March 2005 (second issue)
6. Community care tops medical care at preventing heart disease in black Americans
7. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
8. Obesity among African-American stroke survivors increases risk factors for recurrent stroke
9. Awards & fellowships at the International & American Association for Dental Research General Session
10. American Academy of Neurology presents 57th Annual Meeting in Miami Beach
11. News tips from the 2005, 54th Annual Scientific Sessions of the American College of Cardiology

Post Your Comments:
(Date:8/1/2014)... Cannabis use among young people has spiked, with 29.3 ... marijuana at least once and 17 percent admitting to regular ... Say ‘Yes to Life,’ volunteers from the Church of Scientology ... factual information about drugs, to help reverse this alarming trend. ... Drugs, Say ‘Yes’ to Life,” volunteers have distributed 40,000 copies ...
(Date:8/1/2014)... brain plays a central role in regulating appetite and ... in the brain,s control of food intake and body ... process has been unclear. A new study ... that PPARγ activity in a type of neuron known ... response to high-fat diet. Sabrina Diano and colleagues ...
(Date:8/1/2014)... -- The U.S. Food and Drug Administration announced on ... help fight type 2 diabetes. Jardiance (empagliflozin) ... regimens to control blood sugar levels in the overall ... Office of Drug Evaluation II in the FDA,s Center ... statement. The FDA also recommended that Jardiance be ...
(Date:8/1/2014)... 01, 2014 Summer is here, and with ... during the summer, and they can be a pain for ... to help all their customers get rid of ticks and ... 6,000 eggs in the summer, which is why they are ... tall grass and woodland areas and carry a number of ...
(Date:8/1/2014)... benefits of a cancer diagnosis may improve health outcomes ... conducted by a researcher at the University of Houston ... writing intervention is the writing instruction. Otherwise, writing is ... a journal can be therapeutic, but oftentimes we don,t ... or not," said Qian Lu, assistant professor and director ...
Breaking Medicine News(10 mins):Health News:Addressing a Serious Issue Affecting German Teens 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:Tis the Season for Tick Prevention 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3
(Date:7/31/2014)... SARASOTA, Fla. , July 31, 2014 ... announced today that it has initiated the development of ... ; and that it has selected Quotient Clinical, ... United Kingdom (UK) to run its early ... a Clinical Trial Application (CTA) by the end of ...
(Date:7/31/2014)... Mass. , July 31, 2014  Decision Resources ... technology market intelligence product Marketrack to now include ChinaTrack; ... device landscape in an interactive dashboard providing detailed ... procedure volumes at a hospital level. Other ... , Updated data feed: In addition to end-user surveys ...
(Date:7/31/2014)... VALLEJO, Calif. , July 31, 2014 ... announce it has been selected as the recipient of ... Foundation, which will allow the University to increase research ... is about creating state-of-the-art technology for the study of ... that enhance the diverse needs and interests of our ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2Touro University California Garners Grant From Long Foundation 2
Cached News: